Disseminated histoplasmosis in immunosuppressed patients with non-specific clinical manifestations: Case report
Histoplasmosis diseminada en paciente inmunosuprimido con manifestaciones clínicas poco específicas: Reporte de caso
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
The present case concerns a 37-year-old male patient from Puerto Santander (Norte de Santander), hospitalized at the Erasmo Meoz University Hospital due to acute abdominal pain. The invasive KOH fiber bronchoscopy study of the lung sample showed yeasts, starting with empirical treatment with itraconazole 200 mg every 8 hours for 3 days, followed by 200 mg every 12 hours for 6 weeks. The pathology report has already been made that speaks of intracellular blastoconidia in lung and lymph node samples. Given this, liposomal amphotericin was given 3 mg per kilogram per day for two weeks. He was left under observation until his clinical improvement and subsequent hospital discharge
Article visits 50 | PDF visits
Downloads
- Bonifaz Trujillo J, editor. Histoplasmosis. In: Micología médica básica, 5e. McGraw Hill; 2015. Disponible en: https://accessmedicina.mhmedical.com/content.aspx?bookid=1529§ionid=98867733
- Aidé MA. Chapter 4--histoplasmosis. J Bras Pneumol. 2009 Nov;35(11):1145-51. English, Portuguese. doi: 10.1590/s1806-37132009001100013. PMID: 20011851
- Oladele RO, Ayanlowo OO, Richardson MD, Denning DW. Histoplasmosis in
- Africa: An emerging or a neglected disease? PLoS Negl Trop Dis. 2018 Jan 18;12(1). doi: 10.1371/journal.pntd.0006046. PMID: 29346384; PMCID: PMC5773084.
- Mittal J, Ponce MG, Gendlina I, Nosanchuk JD. Histoplasma Capsulatum: Mechanisms for Pathogenesis. Curr Top Microbiol Immunol. 2019;422:157-191. doi: 10.1007/82_2018_114. PMID: 30043340; PMCID: PMC7212190.
- Tobón ÁM. Protocolo de estudio y manejo de histoplasmosis. Infectio. 2012;16:126-128. doi: 10.1016/s0123-9392(12)70039-5
- Negroni R. Histoplasmosis en América Latina. Biomedica. 2011;31(3):301. doi: 10.7705/biomedica.v31i3.597
- Landaeta ME, Colella MT, Caldera J, Roselló A, Mata-Essayag S. Presentaciones atípicas de histoplasmosis. Amc Acta medica colombiana. 2015. doi: 10.36104/amc.2015.527
- Ordóñez Blanco IT, Garzón Herazo JR, Lasso Apráes JI, Cruz Ramírez V. Histoplasmosis pulmonar crónica en un adulto inmunocompetente. Rev Colomb Neumol. 2018;29(2):67-73. doi: 10.30789/rcneumologia.v29.n2.2017.269
- Scully MC, Baddley JW. Epidemiología de la histoplasmosis. Curr Fungal Infect Rep. 2018;12:51–58. doi: 10.1007/s12281-018-0309-x
- Linder KA, Kauffman CA. Histoplasmosis: Epidemiology, Diagnosis, and Clinical Manifestations. Curr Fungal Infect Rep. 2019;13:120–128. doi: 10.1007/s12281-019-00341-x
- Centers for Disease Control and Prevention. Histoplasmosis Statistics [Internet]. Disponible en: : https://www.cdc.gov/histoplasmosis/php/statistics/index.html
Information
Journal history
Keywords
QR code
Funding
Directories and indexes
